Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2024 Jan-Dec:18:17534666241246428.
doi: 10.1177/17534666241246428.

Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China

Affiliations
Observational Study

Impression life with pulmonary hypertension: clinically relevant characteristics and quality of life among patients in Gansu, China

Juxia Zhang et al. Ther Adv Respir Dis. 2024 Jan-Dec.

Abstract

Background: The adverse effects of pulmonary arterial hypertension (PAH) on physical, emotional, and health-related quality of life (HRQoL) remain primarily unrecognized, especially in resource-limited settings.

Objectives: This study aims to characterize the HRQoL of patients with PAH in this area and also identify the potential role of clinically relevant characteristics, including the 6-min walk distance test (6MWD), WHO-Functional Classification (WHO-FC), and mental health in the occurrence of lowering quality of life.

Design: This was a cross-sectional observational study.

Methods: Inpatients with PAH were chosen from a tertiary hospital located in Gansu province, China. All participants were interviewed face-by-face by using questionnaires, including items from the 36-Item Short Form Health Survey (SF-36), the self-rating anxiety scale, and the self-rating depression scale. Data on demographic and clinically relevant characteristics, including WHO-FC and 6MWD, were also collected by tracing medical recorders. Multiple linear regression analysis was used to determine the association between demographic, clinically relevant characteristics data, and physical component summary (PCS) or mental component summary (MCS) in SF-36.

Results: Of the 152 participants, SF-36 differed significantly from Chinese norms in all eight domains, with role-physical (21.55 ± 9.87) less than one-third of the norm (88.79 ± 28.49). Multiple linear regression results showed that the factors with the greatest impact on PCS were anxiety scores (β = -0.22, p = 0.001), followed by WHO-FC (β = -0.16, p = 0.014) and 6MWD (β = 0.15, p = 0.036). The factors with the greatest impact on MCS were WHO-FC (β = -0.30, p < 0.001), followed by anxiety (β = -0.23, p = 0.001) and depression scores (β = -0.16, p = 0.013).

Conclusion: HRQoL was substantially reduced among PAH patients in the resource-limited area, mainly the physiological functions. WHO-FC and anxiety scores were independently associated with both PCS and MCS in SF-36. Clinicians should make reasonable rehabilitation programs and plans for patients according to their cardiac function grade and the severity of clinical symptoms. In addition, psychological interventions should also be taken, especially for those with anxiety symptoms, so as to improve their HRQoL.

Keywords: 6MWD; HRQoL; MCS; PAH; PCS; WHO-FC.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there is no conflict of interest.

Figures

Figure 1.
Figure 1.
Mean scores of SF-36 for PAH patients versus Chinese population norms. BP, bodily pain; GH, general health; MH, mental health; PAH, pulmonary arterial hypertension; PF, physical functioning; RE, role-emotional; RP, role-physical; SF, social functioning; VT, vitality. *p < 0.05.
Figure 2.
Figure 2.
Associations between the anxiety and depression scores and PCS (a, b) and MCS (c, d). MCS, Mental Component Total Score; PCS, Physical Component Total Score.

Similar articles

Cited by

References

    1. Deshwal H, Weinstein T, Sulica R. Advances in the management of pulmonary arterial hypertension. J Investig Med 2021; 69: 1270–1280. - PMC - PubMed
    1. Galiè N, Humbert M, Vachiery JL, et al.. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J 2015; 46: 903–975. - PubMed
    1. Helgeson SA, Menon D, Helmi H, et al.. Psychosocial and financial burden of therapy in USA patients with pulmonary arterial hypertension. Diseases 2020; 8: 22. - PMC - PubMed
    1. Chen Y, Li F, Luo J, et al.. Comparative efficacy and safety of targeted therapies for chronic thromboembolic pulmonary hypertension: a systematic review and network meta-analysis. Can Respir J 2021; 2021: 1626971. - PMC - PubMed
    1. Reis A, Santos M, Vicente M, et al.. Health-related quality of life in pulmonary hypertension and its clinical correlates: a cross-sectional study. Biomed Res Int 2018; 2018: 3924517. - PMC - PubMed

Publication types

MeSH terms